Yep
The company stated they were confident the DFS would land Q1 2022. That kept getting pushed back throughout 2022. Then Dicko came on board and pushed it out to "mid 2023". Now its slated for End of 2023.
The updated timeline has blown out. Given the company's track record, things will blow out further. So the 2027 for initial production will slip and slide to 2028 best case.
It's bad. Very bad
- Forums
- ASX - By Stock
- LKE
- Ann: Investor Operational Update
Ann: Investor Operational Update, page-17
-
- There are more pages in this discussion • 320 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LKE (ASX) to my watchlist
|
|||||
Last
3.8¢ |
Change
-0.002(5.00%) |
Mkt cap ! $63.40M |
Open | High | Low | Value | Volume |
4.0¢ | 4.1¢ | 3.8¢ | $230.1K | 5.879M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
45 | 4289511 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 160348 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
44 | 4189511 | 0.038 |
29 | 2802808 | 0.037 |
25 | 1850530 | 0.036 |
30 | 3837186 | 0.035 |
6 | 643852 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 160348 | 3 |
0.040 | 773696 | 12 |
0.041 | 662845 | 7 |
0.042 | 687425 | 8 |
0.043 | 478131 | 4 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
LKE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online